June 26, 2020 / 1:12 AM / 17 days ago

BRIEF-FDA Approves Fintepla® To Treat Seizures Associated With Dravet Syndrome

June 25 (Reuters) - Zogenix Inc:

* FDA APPROVES FINTEPLA® (FENFLURAMINE) FOR THE TREATMENT OF SEIZURES ASSOCIATED WITH DRAVET SYNDROME

* COMMERCIAL LAUNCH OF FINTEPLA PLANNED FOR JULY 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below